Associated tags: Enzyme, RNA, Vaccine, PCR, Therapy, NEB, Synthetic biology, Gene expression, Molecular biology, New England Biolabs, Research, DNA, Fine chemical
Locations: JAPAN, FRANCE, CHINA, SINGAPORE, AUSTRALIA, CANADA, GERMANY, MASSACHUSETTS, KOREA, UNITED KINGDOM, NEW ZEALAND, NEBRASKA, MA, USA, NEW ENGLAND, UK
Saliva,
RNA,
Research,
Monarch,
New England Biolabs,
Automation,
DNA,
NEB,
Virus,
Plastic,
Infection,
Vaccine IPSWICH, Mass., April 11, 2024 /PRNewswire/ -- New England Biolabs (NEB®) announces the release of its Monarch Mag Viral DNA/RNA Extraction Kit. This extraction kit enhances recovery of low amounts of viral nucleic acid to enable highly sensitive detection. The kit uses a magnetic bead-based process to extract viral RNA and DNA reproducibly and efficiently, while enabling scale up for high-throughput automation. The kit is compatible with the most common sample types for extracting viral nucleic acids, including saliva, respiratory swab samples and, following an enrichment step, wastewater samples.
Key Points:
- IPSWICH, Mass., April 11, 2024 /PRNewswire/ -- New England Biolabs (NEB®) announces the release of its Monarch Mag Viral DNA/RNA Extraction Kit.
- This extraction kit enhances recovery of low amounts of viral nucleic acid to enable highly sensitive detection.
- The kit uses a magnetic bead-based process to extract viral RNA and DNA reproducibly and efficiently, while enabling scale up for high-throughput automation.
- The Monarch Mag Viral DNA/RNA Extraction Kit complements NEB's downstream amplification and library prep for next-generation sequencing applications, and can be utilized with these product lines accordingly.
IPSWICH, Mass., April 3, 2024 /PRNewswire/ -- New England Biolabs (NEB®), a world leader in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Korea Ltd. (NEB Korea).
Key Points:
- IPSWICH, Mass., April 3, 2024 /PRNewswire/ -- New England Biolabs (NEB®), a world leader in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Korea Ltd. (NEB Korea).
- The Republic of Korea is emerging as a global leader in the life science space, as a result of strong public sector support and private sector investments.
- NEB Korea will now bring a higher level of service to our valued customers and local distributors in this important market.
- NEB also maintains subsidiary offices in Australia, Canada, China, France, Germany, Japan, New Zealand, Singapore and the United Kingdom.
IPSWICH, Mass., April 1, 2024 /PRNewswire/ -- In commemoration of its 50th anniversary, New England Biolabs (NEB®) today announced an invitation for scientists to submit applications for its 2024 Passion in Science Awards, which recognize members of the scientific community who are committed to making a difference through their science, humanitarian service, environmental stewardship, and/or artistic and creative spirit. Awardees will be celebrated on October 9th and 10th at the NEB campus in Ipswich, MA, USA.
Key Points:
- "In 2014, NEB introduced the Passion in Science Awards to recognize those within the scientific community working to solve many of today's challenges.
- "We are thrilled to be hosting the Passion in Science Awards again this year as part of our 50th anniversary celebration."
- "It is fitting to host the Passion in Science Awards as part of our 50th anniversary celebration."
- NEB will be hosting other 50th anniversary events throughout the year, including its 50-stop World Tour, Donald G. Comb Memorial Lecture, and various special offers.
Retrieved on:
Tuesday, February 13, 2024
IPSWICH, Mass., Feb. 13, 2024 /PRNewswire/ -- New England Biolabs (NEB®) today announced the launch of the NEBNext Enzymatic 5hmC-seq Kit (E5hmC-seq™), a novel enzyme-based method for the specific detection of 5hmC sites. The gentle, enzyme-based approach enables high yields and high-quality data, with an input range of 100 pg to 200 ng.
Key Points:
- IPSWICH, Mass., Feb. 13, 2024 /PRNewswire/ -- New England Biolabs (NEB®) today announced the launch of the NEBNext Enzymatic 5hmC-seq Kit (E5hmC-seq™), a novel enzyme-based method for the specific detection of 5hmC sites.
- "While NEBNext Enzymatic Methyl-seq (EM-seq™), our gold standard for methylation detection, detects both 5mC and 5hmC, it does not distinguish between them.
- "To address these challenges, we developed the NEBNext Enzymatic 5hmC-seq Kit, which allows for the specific detection of 5hmC sites using a two-step enzymatic conversion workflow," said Stewart.
- "The enzymatic method minimizes DNA damage and allows for the discrimination of 5hmC from unmodified cytosine and 5mC after Illumina® sequencing.
RNA,
Associate Director of National Intelligence and Chief Information Officer,
PCR,
Fungus,
University of Massachusetts Amherst,
Messenger,
Workflow,
University,
NEB,
Library,
Plastic,
New England Biolabs,
DNA,
Automation,
Vaccine,
Illumina IPSWICH, Mass., Nov. 3, 2023 /PRNewswire/ -- New England Biolabs (NEB®) today announced the release of the NEBNext UltraExpress DNA and RNA Library Prep Kits for next generation sequencing on the Illumina platform. These new kits are designed to generate high-quality, high-yield libraries with a faster, easier workflow, enabling RNA library prep in a single day, and DNA library prep in under two hours. The kits are suitable for a wide range of inputs (25 -250 ng total RNA and 10 – 200 ng mechanically sheared DNA) and utilize a single protocol that uses the same adaptor concentration and PCR cycle number for all input amounts. The workflows are automation friendly and minimize consumables waste.
Key Points:
- IPSWICH, Mass., Nov. 3, 2023 /PRNewswire/ -- New England Biolabs (NEB®) today announced the release of the NEBNext UltraExpress DNA and RNA Library Prep Kits for next generation sequencing on the Illumina platform.
- These new kits are designed to generate high-quality, high-yield libraries with a faster, easier workflow, enabling RNA library prep in a single day, and DNA library prep in under two hours.
- "We designed the NEBNext UltraExpress workflows to meet the need for substantially faster and easier library prep of samples within a standard input range.
- Compared to the NEBNext® Ultra™ II Directional RNA kit, NEBNext UltraExpress RNA uses 21% fewer tubes and 25% fewer tips.
Molecular biology,
Nobel Prize,
DNA,
National academy,
NAS,
CSO,
Parasitology,
RNA,
Science,
Rich,
Publication,
Genome,
Humble Oil,
NEB,
2021 Nobel Prize in Physiology or Medicine,
Intron,
New England Biolabs,
Pharmaceutical industry,
Research,
Medicine,
Physiology IPSWICH, Mass., June 8, 2023 /PRNewswire/ -- Today, New England Biolabs (NEB®) announced that Sir Richard Roberts, Nobel Prize winner and Chief Scientific Officer (CSO) at NEB, has been inducted into the National Academy of Sciences (NAS), a private, nonprofit society of distinguished scientific scholars committed to furthering science and scientific research in the USA. Scientists elected to NAS are selected by their peers based on their exceptional contributions in research.
Key Points:
- IPSWICH, Mass., June 8, 2023 /PRNewswire/ -- Today, New England Biolabs (NEB®) announced that Sir Richard Roberts, Nobel Prize winner and Chief Scientific Officer (CSO) at NEB, has been inducted into the National Academy of Sciences (NAS), a private, nonprofit society of distinguished scientific scholars committed to furthering science and scientific research in the USA.
- Scientists elected to NAS are selected by their peers based on their exceptional contributions in research.
- "I've been very fortunate to witness my research contribute to our evolving understanding of the life sciences over the course of my career," said Roberts.
- He served as a consultant and chairman of NEB's scientific advisory board from 1975 and joined the company as CSO in 1992.
NEB,
DNA,
NGS,
Genomics,
Library,
Ultima,
Associate,
New England Biolabs,
Molecular biology,
RNA,
Fine chemical As part of the collaboration, the parties will develop optimized next generation sequencing (NGS) workflows to support DNA, RNA, and methylation sequencing applications.
Key Points:
- As part of the collaboration, the parties will develop optimized next generation sequencing (NGS) workflows to support DNA, RNA, and methylation sequencing applications.
- An important initial step in successful NGS is high quality and consistent library preparation.
- "This collaboration demonstrates our commitment to provide high performance end-to-end workflows to our customers," said Doron Lipson, Chief Scientific Officer of Ultima Genomics.
- "We're excited to see the Ultima Genomics platform be adopted by scientists to help solve important problems," stated Fiona Stewart, Associate Director of NGS Portfolio Management at NEB.
Retrieved on:
Thursday, December 1, 2022
Inc.,
FGL,
RNA,
Multimedia,
Enzyme,
PCR,
Business operations,
ENGLAND,
OEM,
Molecular biology,
Therapy,
NEB,
Gene expression,
Synthetic biology,
Vaccine,
Acquisition,
Oil,
Fine chemical,
Medicine,
New England Biolabs IPSWICH, Mass., Dec. 1, 2022 /PRNewswire/ -- New England Biolabs (NEB®), a leading supplier of life science reagents, introduces New England Biolabs Lyophilization Sciences (NEB Lyo Sciences™) – a wholly owned subsidiary of NEB with expertise in the design, development and manufacturing of innovative solutions for ambient stored products.
Key Points:
- IPSWICH, Mass., Dec. 1, 2022 /PRNewswire/ -- New England Biolabs (NEB), a leading supplier of life science reagents, introduces New England Biolabs Lyophilization Sciences (NEB Lyo Sciences) a wholly owned subsidiary of NEB with expertise in the design, development and manufacturing of innovative solutions for ambient stored products.
- In May 2021, NEB acquired Fluorogenics Limited (FGL), facilitating the combination of NEB's expertise in enzymology with FGL's extensive understanding of the lyophilization process.
- NEB will continue to incorporate the capabilities of NEB Lyo Sciences into its existing OEM and Customized Solutions business, expanding the services that it offers.
- NEW ENGLAND BIOLABSand NEBare registered trademarks of New England Biolabs, Inc.
NEW ENGLAND BIOLABS LYOPHILIZATION SCIENCES, NEB LYO SCIENCES and LYOPRIME are trademarks of New England Biolabs, Inc.
View original content to download multimedia: https://www.prnewswire.com/news-releases/new-england-biolabs-introduces-...
Multimedia,
Synthetic biology,
RNA transfection,
Industry,
NEW,
Gene expression,
ENGLAND,
Infection,
Molecular biology,
ISO 9001,
Research,
Enzyme,
Faustovirus,
Compliance,
Hazardous waste,
View,
Therapy,
Vaccine,
GMP,
RNA,
NEB,
Active ingredient,
ISO,
PCR,
API,
Efficiency,
Temperature,
FCE,
VCE,
Fine chemical,
New England Biolabs IPSWICH, Mass., Aug. 9, 2022 /PRNewswire/ -- Today, New England Biolabs (NEB®) announces the release of the Faustovirus Capping Enzyme (FCE), an mRNA capping solution that combines high activity and a broad temperature range to support mRNA therapeutic manufacturing needs.
Key Points:
- New enzyme improves capping efficiency and scalability for mRNA manufacturing workflows, including vaccine generation
IPSWICH, Mass., Aug. 9, 2022 /PRNewswire/ -- Today, New England Biolabs (NEB) announces the release of the Faustovirus Capping Enzyme (FCE), an mRNA capping solution that combines high activity and a broad temperature range to support mRNA therapeutic manufacturing needs.
- This new product offers a streamlined, scalable, and cost-effective solution for mRNA capping for both research and therapeutic applications."
- "For large-scale mRNA production, I have always favored post-transcriptional enzymatic capping due to the significant advantages in terms of yield.
- NEB and NEW ENGLAND BIOLABS are registered trademarks of New England Biolabs, Inc.
View original content to download multimedia: https://www.prnewswire.com/news-releases/new-england-biolabs-introduces-...
Synthetic biology,
PerkinElmer,
View,
Science,
CEO,
Research,
Caliper Life Sciences,
Cell Signaling Technology,
Enzyme,
Growth,
Gene expression,
Industry,
Reagent,
Cell,
Business development,
NEB,
Therapy,
Retirement,
Certification,
Marketing,
OEM,
ISO,
RNA,
DNA,
Health,
NEW,
Ellard,
PCR,
Family,
Board,
Vaccine,
Molecular biology,
Leadership,
Associate,
Multimedia,
Management,
Oil,
New England Biolabs,
Francesca Russello Ammon IPSWICH, Mass., July 7, 2022 /PRNewswire/ -- New England Biolabs (NEB®), a pioneer in the field of molecular biology and global supplier of reagents to the life science industry, today announced that its long-time Chief Executive Officer, Jim Ellard, will retire, effective August 15th, 2022. Ellard, who's been with the company for 39 years, 17 years as CEO, will remain Chairman of the Board. Dr. Salvatore (Sal) Russello, currently NEB's Director of OEM & Customized Solutions, has been appointed as his successor. Russello will become only the third person to lead NEB since it was founded in 1974.
Key Points:
- IPSWICH, Mass., July 7, 2022 /PRNewswire/ -- New England Biolabs (NEB), a pioneer in the field of molecular biology and global supplier of reagents to the life science industry, today announced that its long-time Chief Executive Officer, Jim Ellard, will retire, effective August 15th, 2022.
- Ellard joined NEB in 1984 and has served as CEO since 2005, when founder, Dr. Donald G. Comb, transitioned into retirement.
- For more information about New England Biolabs, Inc., visit www.neb.com .
- NEW ENGLAND BIOLABS and NEB are registered trademarks of New England Biolabs, Inc.
View original content to download multimedia: https://www.prnewswire.com/news-releases/new-england-biolabs-chief-execu...
